176 related articles for article (PubMed ID: 34982455)
21. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Deng Y; Tong Y; Deng Y; Zou L; Li S; Chen H
J Am Heart Assoc; 2019 Jul; 8(14):e012540. PubMed ID: 31310583
[TBL] [Abstract][Full Text] [Related]
22. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
Sterne JA; Bodalia PN; Bryden PA; Davies PA; López-López JA; Okoli GN; Thom HH; Caldwell DM; Dias S; Eaton D; Higgins JP; Hollingworth W; Salisbury C; Savović J; Sofat R; Stephens-Boal A; Welton NJ; Hingorani AD
Health Technol Assess; 2017 Mar; 21(9):1-386. PubMed ID: 28279251
[TBL] [Abstract][Full Text] [Related]
23. The Quality of Anticoagulation Therapy among Warfarin-Treated Patients with Atrial Fibrillation in a Primary Health Care Setting.
Urbonas G; Valius L; Šakalytė G; Petniūnas K; Petniūnienė I
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30650565
[No Abstract] [Full Text] [Related]
24. Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review.
Adam SS; McDuffie JR; Ortel TL; Williams JW
Ann Intern Med; 2012 Dec; 157(11):796-807. PubMed ID: 22928173
[TBL] [Abstract][Full Text] [Related]
25. Barriers and enablers to adherence to anticoagulation in heart failure with atrial fibrillation: patient and provider perspectives.
Ferguson C; Inglis SC; Newton PJ; Middleton S; Macdonald PS; Davidson PM
J Clin Nurs; 2017 Dec; 26(23-24):4325-4334. PubMed ID: 28178370
[TBL] [Abstract][Full Text] [Related]
26. Long-Term Persistence with Newly-Initiated Warfarin or Non-VKA Oral Anticoagulant (NOAC) in Patients with Non-Valvular Atrial Fibrillation: Insights from the Prospective China-AF Registry.
Liu C; Du X; Jiang C; He L; Chang SS; Guo XY; Yu RH; Long DY; Bai R; Liu N; Sang CH; Jiang CX; Dong JZ; Lip GYH; Ma CS
Med Sci Monit; 2019 Apr; 25():2649-2657. PubMed ID: 30971681
[TBL] [Abstract][Full Text] [Related]
27. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
[TBL] [Abstract][Full Text] [Related]
28. Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis.
Reynolds MW; Fahrbach K; Hauch O; Wygant G; Estok R; Cella C; Nalysnyk L
Chest; 2004 Dec; 126(6):1938-45. PubMed ID: 15596696
[TBL] [Abstract][Full Text] [Related]
29. Non-Vitamin K Antagonists Versus Warfarin in Patients with Atrial Fibrillation and Bioprosthetic Valves: A Systematic Review and Meta-Analysis.
Cardoso R; Ternes CMP; Justino GB; Fernandes A; Rocha AV; Knijnik L; d'Avila A; Lopes RD
Am J Med; 2022 Feb; 135(2):228-234.e1. PubMed ID: 34634252
[TBL] [Abstract][Full Text] [Related]
30. Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study.
Clarkesmith DE; Lip GYH; Lane DA
Thromb Res; 2017 May; 153():19-27. PubMed ID: 28314139
[TBL] [Abstract][Full Text] [Related]
31. Prevention of stroke in patients with atrial fibrillation.
Olsson SB; Halperin JL
Semin Vasc Med; 2005 Aug; 5(3):285-92. PubMed ID: 16123916
[TBL] [Abstract][Full Text] [Related]
32. Development of a conceptual model of adherence to oral anticoagulants to reduce risk of stroke in patients with atrial fibrillation.
Brown TM; Siu K; Walker D; Pladevall-Vila M; Sander S; Mordin M
J Manag Care Pharm; 2012 Jun; 18(5):351-62. PubMed ID: 22663168
[TBL] [Abstract][Full Text] [Related]
33. TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT).
Smith DE; Xuereb CB; Pattison HM; Lip GY; Lane DA
BMC Cardiovasc Disord; 2010 May; 10():21. PubMed ID: 20487528
[TBL] [Abstract][Full Text] [Related]
34. Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
Dallalzadeh LO; Go AS; Chang Y; Borowsky LH; Fang MC; Singer DE
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27451456
[TBL] [Abstract][Full Text] [Related]
35. Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.
Pan KL; Singer DE; Ovbiagele B; Wu YL; Ahmed MA; Lee M
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28720644
[TBL] [Abstract][Full Text] [Related]
36. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
Hirano T; Kaneko H; Mishina S; Wang F; Morita S
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
[TBL] [Abstract][Full Text] [Related]
37. Quality of Warfarin Anticoagulation in Indigenous and Non-Indigenous Australians With Atrial Fibrillation.
Nguyen MT; Gallagher C; Pitman BM; Emami M; Kadhim K; Hendriks JM; Middeldorp ME; Roberts-Thomson KC; Mahajan R; Lau DH; Sanders P; Wong CX
Heart Lung Circ; 2020 Aug; 29(8):1122-1128. PubMed ID: 31980393
[TBL] [Abstract][Full Text] [Related]
38. Atrial Fibrillation Patients Treated With Long-Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long-Term Warfarin for Other Indications.
Bunch TJ; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Jacobs V; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27402230
[TBL] [Abstract][Full Text] [Related]
39. Anticoagulation therapy for patients with non-valvular atrial fibrillation: comparison of decision analytic model recommendations and real-world warfarin prescription use.
Casciano JP; Singer DE; Kwong WJ; Fox ES; Martin BC
Am J Cardiovasc Drugs; 2012 Oct; 12(5):313-23. PubMed ID: 22920047
[TBL] [Abstract][Full Text] [Related]
40. Predicting outcomes among patients with atrial fibrillation and heart failure receiving anticoagulation with warfarin.
Kim EJ; Ozonoff A; Hylek EM; Berlowitz DR; Ash AS; Miller DR; Zhao S; Reisman JI; Jasuja GK; Rose AJ
Thromb Haemost; 2015 Jul; 114(1):70-7. PubMed ID: 25948532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
